Moody Aldrich Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History

Moody Aldrich Partners’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$3.96M	Sell
2025 Q1	$4.69M	Sell
2024 Q4	$7.38M	Buy
2024 Q3	$7.11M	Sell
2024 Q2	$6.73M	Buy
2024 Q1	$2.64M	Buy
2023 Q4	–	Sell
2023 Q3	$1.84M	Buy